1. Home
  2. CGON vs B Comparison

CGON vs B Comparison

Compare CGON & B Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGON
  • B
  • Stock Information
  • Founded
  • CGON 2010
  • B 1857
  • Country
  • CGON United States
  • B United States
  • Employees
  • CGON N/A
  • B N/A
  • Industry
  • CGON
  • B Metal Fabrications
  • Sector
  • CGON
  • B Industrials
  • Exchange
  • CGON NYSE
  • B Nasdaq
  • Market Cap
  • CGON 2.4B
  • B 2.4B
  • IPO Year
  • CGON 2024
  • B N/A
  • Fundamental
  • Price
  • CGON $28.45
  • B $47.16
  • Analyst Decision
  • CGON Strong Buy
  • B Hold
  • Analyst Count
  • CGON 8
  • B 3
  • Target Price
  • CGON $63.88
  • B $47.67
  • AVG Volume (30 Days)
  • CGON 819.4K
  • B 530.1K
  • Earning Date
  • CGON 02-02-2025
  • B 02-14-2025
  • Dividend Yield
  • CGON N/A
  • B 1.36%
  • EPS Growth
  • CGON N/A
  • B N/A
  • EPS
  • CGON N/A
  • B N/A
  • Revenue
  • CGON $684,000.00
  • B $1,616,206,000.00
  • Revenue This Year
  • CGON $165.75
  • B $12.62
  • Revenue Next Year
  • CGON $47.04
  • B $3.55
  • P/E Ratio
  • CGON N/A
  • B N/A
  • Revenue Growth
  • CGON 258.12
  • B 19.83
  • 52 Week Low
  • CGON $25.77
  • B $29.68
  • 52 Week High
  • CGON $50.23
  • B $47.40
  • Technical
  • Relative Strength Index (RSI)
  • CGON 31.50
  • B 71.61
  • Support Level
  • CGON $27.58
  • B $46.95
  • Resistance Level
  • CGON $36.73
  • B $47.20
  • Average True Range (ATR)
  • CGON 2.01
  • B 0.09
  • MACD
  • CGON -0.52
  • B -0.05
  • Stochastic Oscillator
  • CGON 9.51
  • B 85.90

About CGON CG ONCOLOGY INC

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.

About B Barnes Group Inc.

Barnes Group Inc is a U.S. based industrial and aerospace manufacturer and service provider. It leverages world-class manufacturing capabilities and engineering to develop various processes, automation solutions, and applied technologies for industries ranging from aerospace and medical & personal care to mobility and packaging. The company operates through two segments: Industrial and Aerospace. The industrial segment manufactures precision parts, products, and systems for critical applications in end markets including transportation, industrial equipment, and consumer products. The aerospace segment provides machined components and assemblies for original equipment manufacturer turbine engine, airframe and industrial gas turbine builders, and the military.

Share on Social Networks: